PIK3R4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.837600E-01
Normal-vs-Stage2
8.530000E-01
Normal-vs-Stage3
9.424500E-02
Normal-vs-Stage4
4.118800E-01
Stage1-vs-Stage2
4.913800E-01
Stage1-vs-Stage3
5.455700E-03
Stage1-vs-Stage4
4.421200E-01
Stage2-vs-Stage3
1.284220E-01
Stage2-vs-Stage4
6.532400E-02
Stage3-vs-Stage4
1.051810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.382000E-01
Normal-vs-AfricanAmerican
7.863800E-01
Normal-vs-Asian
5.893200E-01
Caucasian-vs-AfricanAmerican
4.643600E-01
Caucasian-vs-Asian
4.389600E-01
AfricanAmerican-vs-Asian
3.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.985000E-01
Normal-vs-Female
8.036200E-01
Male-vs-Female
7.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.700600E-01
Normal-vs-Age(41-60Yrs)
8.800200E-01
Normal-vs-Age(61-80Yrs)
7.427200E-01
Normal-vs-Age(81-100Yrs)
7.951400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.518000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.660200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.116600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.027600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.308000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.775200E-01
Normal-vs-Daily Drinker
2.641200E-01
Normal-vs-Weekly Drinker
4.274200E-01
Normal-vs-Occasional Drinker
5.925000E-01
Normal-vs-Social Drinker
9.227800E-01
Non Drinker-vs-Daily Drinker
4.093200E-01
Non Drinker-vs-Weekly Drinker
6.589600E-01
Non Drinker-vs-Occasional Drinker
2.853600E-02
Non Drinker-vs-Social Drinker
1.473630E-01
Daily Drinker-vs-Weekly Drinker
8.270400E-01
Daily Drinker-vs-Occasional Drinker
8.535600E-03
Daily Drinker-vs-Social Drinker
4.718400E-02
Weekly Drinker-vs-Occasional Drinker
3.388400E-02
Weekly Drinker-vs-Social Drinker
1.500410E-01
Occasional Drinker-vs-Social Drinker
3.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.119190E-01
Normal-vs-Grade 2
2.303700E-02
Normal-vs-Grade 3
4.017600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.646760E-01
Grade 1-vs-Grade 3
1.229700E-02
Grade 1-vs-Grade 4
1.119190E-01
Grade 2-vs-Grade 3
4.156400E-02
Grade 2-vs-Grade 4
2.303700E-02
Grade 3-vs-Grade 4
4.017600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.792000E-01
Normal-vs-NonDiabetic
7.655600E-01
Diabetic-vs-NonDiabetic
5.255800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.474800E-01
Normal-vs-NoPancreatitis
7.778800E-01
Pancreatitis-vs-NoPancreatitis
7.436000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.660400E-01
Normal-vs-N1
8.659600E-01
N0-vs-N1
9.881200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.319400E-01
Normal-vs-TP53-NonMutant
9.401800E-01
TP53-Mutant-vs-TP53-NonMutant
1.219760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
